Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningitis | 2 | 2019 | 18 | 1.040 |
Why?
|
| Guillain-Barre Syndrome | 5 | 2026 | 10 | 1.020 |
Why?
|
| Neural Conduction | 4 | 2026 | 32 | 0.650 |
Why?
|
| Encephalomyelitis | 1 | 2019 | 4 | 0.630 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2019 | 12 | 0.620 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 6 | 2004 | 8 | 0.610 |
Why?
|
| Spinal Cord | 1 | 2019 | 206 | 0.580 |
Why?
|
| Lamin Type A | 4 | 2003 | 13 | 0.500 |
Why?
|
| Fluconazole | 1 | 2013 | 13 | 0.420 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 12 | 0.420 |
Why?
|
| Brain | 2 | 2019 | 1581 | 0.400 |
Why?
|
| Antifungal Agents | 1 | 2013 | 128 | 0.390 |
Why?
|
| Electrodiagnosis | 3 | 2026 | 19 | 0.320 |
Why?
|
| Mutation | 4 | 2003 | 2629 | 0.270 |
Why?
|
| Tranylcypromine | 1 | 2007 | 2 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 2218 | 0.260 |
Why?
|
| Chorea | 1 | 2007 | 10 | 0.260 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2004 | 158 | 0.260 |
Why?
|
| Heart Conduction System | 2 | 2004 | 53 | 0.250 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 65 | 0.250 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 61 | 0.250 |
Why?
|
| Muscular Dystrophy, Oculopharyngeal | 1 | 2025 | 3 | 0.230 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 226 | 0.230 |
Why?
|
| Myotonic Dystrophy | 1 | 2025 | 14 | 0.230 |
Why?
|
| Myoclonus | 1 | 2004 | 1 | 0.220 |
Why?
|
| Spinal Osteophytosis | 1 | 2004 | 3 | 0.220 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2025 | 44 | 0.220 |
Why?
|
| Skiing | 1 | 2004 | 11 | 0.220 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2004 | 17 | 0.220 |
Why?
|
| Pacemaker, Artificial | 2 | 2004 | 49 | 0.220 |
Why?
|
| Spinal Cord Compression | 1 | 2004 | 30 | 0.220 |
Why?
|
| Heart Diseases | 2 | 2003 | 220 | 0.220 |
Why?
|
| Depressive Disorder | 1 | 2007 | 286 | 0.220 |
Why?
|
| Lamins | 1 | 2003 | 5 | 0.210 |
Why?
|
| Muscular Dystrophies | 1 | 2003 | 11 | 0.210 |
Why?
|
| Methylprednisolone | 2 | 2021 | 38 | 0.200 |
Why?
|
| Cervical Vertebrae | 1 | 2004 | 118 | 0.200 |
Why?
|
| Penetrance | 1 | 2002 | 10 | 0.190 |
Why?
|
| Adult | 14 | 2026 | 17133 | 0.190 |
Why?
|
| Papilledema | 1 | 2021 | 10 | 0.180 |
Why?
|
| Optic Nerve Diseases | 1 | 2021 | 18 | 0.180 |
Why?
|
| Ulnar Neuropathies | 1 | 2021 | 2 | 0.180 |
Why?
|
| Cubital Tunnel Syndrome | 1 | 2021 | 3 | 0.180 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 8 | 0.180 |
Why?
|
| Elbow Joint | 1 | 2021 | 15 | 0.180 |
Why?
|
| Female | 13 | 2026 | 33382 | 0.170 |
Why?
|
| Humans | 22 | 2026 | 64279 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 104 | 0.160 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 41 | 0.160 |
Why?
|
| Middle Aged | 10 | 2026 | 17923 | 0.150 |
Why?
|
| Muscle Weakness | 2 | 2018 | 33 | 0.150 |
Why?
|
| Liver Transplantation | 1 | 2021 | 217 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2019 | 184 | 0.150 |
Why?
|
| Arthrogryposis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2018 | 1 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2019 | 189 | 0.140 |
Why?
|
| Aged | 6 | 2026 | 14664 | 0.130 |
Why?
|
| Male | 14 | 2026 | 30323 | 0.120 |
Why?
|
| Thymopoietins | 3 | 2004 | 3 | 0.120 |
Why?
|
| Neoplasms | 1 | 2025 | 1392 | 0.110 |
Why?
|
| DNA Mutational Analysis | 3 | 2003 | 197 | 0.110 |
Why?
|
| Lyme Disease | 1 | 2015 | 122 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2003 | 38 | 0.100 |
Why?
|
| Adolescent | 6 | 2018 | 6305 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2024 | 2605 | 0.100 |
Why?
|
| Recurrence | 1 | 2013 | 652 | 0.090 |
Why?
|
| Nuclear Proteins | 3 | 2004 | 785 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2004 | 909 | 0.080 |
Why?
|
| Prognosis | 2 | 2023 | 1769 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 126 | 0.060 |
Why?
|
| Child | 4 | 2021 | 4583 | 0.060 |
Why?
|
| Stroke | 1 | 2015 | 1196 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 1669 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 467 | 0.060 |
Why?
|
| Axons | 1 | 2026 | 126 | 0.060 |
Why?
|
| Young Adult | 2 | 2026 | 4781 | 0.060 |
Why?
|
| Acute Disease | 1 | 2007 | 672 | 0.060 |
Why?
|
| Reflex, Babinski | 1 | 2004 | 1 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2004 | 17 | 0.060 |
Why?
|
| Thalidomide | 1 | 2004 | 34 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 28 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2004 | 33 | 0.050 |
Why?
|
| Muscle, Skeletal | 3 | 2004 | 747 | 0.050 |
Why?
|
| Ankle | 1 | 2004 | 28 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2004 | 51 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 25 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2004 | 70 | 0.050 |
Why?
|
| Miller Fisher Syndrome | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2023 | 24 | 0.050 |
Why?
|
| Internationality | 1 | 2023 | 45 | 0.050 |
Why?
|
| Cell Count | 1 | 2023 | 134 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2002 | 42 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2002 | 57 | 0.050 |
Why?
|
| Pedigree | 1 | 2002 | 195 | 0.050 |
Why?
|
| Heterozygote | 1 | 2002 | 171 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 901 | 0.050 |
Why?
|
| Disease Progression | 2 | 2023 | 1176 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2021 | 25 | 0.050 |
Why?
|
| Exons | 1 | 2002 | 201 | 0.050 |
Why?
|
| Ulnar Nerve | 1 | 2021 | 8 | 0.040 |
Why?
|
| Elbow | 1 | 2021 | 11 | 0.040 |
Why?
|
| Reference Values | 1 | 2022 | 333 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2001 | 96 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2025 | 6742 | 0.040 |
Why?
|
| Living Donors | 1 | 2021 | 78 | 0.040 |
Why?
|
| X Chromosome | 1 | 2001 | 46 | 0.040 |
Why?
|
| Genotype | 1 | 2002 | 668 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 198 | 0.040 |
Why?
|
| Phenotype | 1 | 2003 | 1222 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2001 | 130 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2021 | 486 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 371 | 0.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2024 | 508 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 727 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 2621 | 0.030 |
Why?
|
| Arm | 1 | 2018 | 46 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 984 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3318 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 186 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5697 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2015 | 421 | 0.020 |
Why?
|
| Ependymoma | 1 | 2004 | 5 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2004 | 22 | 0.010 |
Why?
|
| Ulcer | 1 | 2004 | 12 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2004 | 53 | 0.010 |
Why?
|
| Withholding Treatment | 1 | 2004 | 39 | 0.010 |
Why?
|
| Electromyography | 1 | 2004 | 97 | 0.010 |
Why?
|
| Action Potentials | 1 | 2004 | 111 | 0.010 |
Why?
|
| Syncope | 1 | 2003 | 42 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 46 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 175 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2004 | 110 | 0.010 |
Why?
|
| Dyspnea | 1 | 2003 | 124 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 313 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 292 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 554 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 509 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2003 | 362 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 2482 | 0.010 |
Why?
|